Capital soughtStartupListing no. AN-1016 · 1 month ago
Biotech start-up, seed round for drug development
Automatically translated from German · Show original
Sample listing. This listing is a fictitious example showing what listings on SwissOwners look like. The company and details are invented; enquiries are not possible.
Sample listingTransfer restrictedPre-emption right
Industry
Biotech and pharma
Canton
Basel-City
Stage
Seed
Founded
2020s
Employees
under 10
Deal type
Equity investment
Revenue range
under CHF 0.5 million
Seeking
CHF 2 million
Valuation
CHF 9 million
Board seat
Not planned
Startup valuation: The price of the last funding round is not a market price. Resales on the secondary market often involve discounts. Check the share class, preferential rights and the shareholders' agreement.
Description
Spin-off from a Swiss university with its own drug discovery platform targeting autoimmune diseases. A lead investor has already committed.
Reason for the offer
Preclinical studies and expansion of the laboratory.
Company
hiddenVisible once the advertiser releases your request
Check before buying: The shares are subject to transfer restrictions – the company must approve the transfer. Existing shareholders have a pre-emption right. The information is provided by the advertiser. SwissOwners is not party to the transaction.